Met Life Investment Management, LLC Bionano Genomics, Inc. Transaction History

Met Life Investment Management, LLC

$16.6 Billion
Q2 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2024	BUY	$1.06 - $1.97 $168,406 - $312,981	158,874 New	158,874 $176 Million
Q1 2023 May 15, 2023	BUY	$1.06 - $1.97 $38,411 - $71,386	36,237 Added 29.55%	158,874 $176,000
Q4 2022 May 10, 2024	SELL	$1.4 - $25.4 $43,765 - $794,029	-31,261 Reduced 20.31%	122,637 $179,000
Q4 2022 Jun 14, 2023	SELL	$1.4 - $25.4 $50,731 - $920,419	-36,237 Reduced 22.81%	122,637 $179,000
Q4 2022 Mar 22, 2023	SELL	$1.4 - $25.4 $43,765 - $794,029	-31,261 Reduced 20.31%	122,637 $179,000
Q4 2022 Feb 15, 2023	SELL	$1.4 - $25.4 $43,765 - $794,029	-31,261 Reduced 20.31%	122,637 $179,000
Q3 2022 Jun 14, 2023	SELL	$0.36 - $36.0 $1,791 - $179,136	-4,976 Reduced 3.13%	153,898 $286,000
Q2 2022 May 10, 2024	BUY	$12.3 - $27.3 $565,529 - $1.26 Million	45,978 Added 42.6%	153,898 $0
Q2 2022 Jun 20, 2023	SELL	$12.3 - $27.3 $61,204 - $135,844	-4,976 Reduced 3.13%	153,898 $0
Q2 2022 Mar 22, 2023	BUY	$12.3 - $27.3 $565,529 - $1.26 Million	45,978 Added 42.6%	153,898 $0
Q2 2022 Aug 11, 2022	BUY	$12.3 - $27.3 $565,529 - $1.26 Million	45,978 Added 42.6%	153,898 $212,000
Q1 2022 May 10, 2024	BUY	$16.6 - $32.3 $1.79 Million - $3.49 Million	107,920 New	107,920 $0
Q1 2022 Jun 20, 2023	SELL	$16.6 - $32.3 $845,836 - $1.65 Million	-50,954 Reduced 32.07%	107,920 $0
Q1 2022 Mar 22, 2023	BUY	$16.6 - $32.3 $63,362 - $123,289	3,817 Added 3.67%	107,920 $0
Q1 2022 May 12, 2022	BUY	$16.6 - $32.3 $63,362 - $123,289	3,817 Added 3.67%	107,920 $278,000
Q4 2021 May 17, 2024	BUY	$29.9 - $61.2 $519,422 - $1.06 Million	17,372 Added 20.03%	104,103 $0
Q4 2021 Jun 21, 2023	SELL	$29.9 - $61.2 $1.64 Million - $3.35 Million	-54,771 Reduced 34.47%	104,103 $0
Q4 2021 Mar 22, 2023	BUY	$29.9 - $61.2 $519,422 - $1.06 Million	17,372 Added 20.03%	104,103 $0
Q4 2021 Feb 15, 2022	BUY	$29.9 - $61.2 $519,422 - $1.06 Million	17,372 Added 20.03%	104,103 $311,000
Q3 2021 May 17, 2024	SELL	$51.4 - $68.2 $797,882 - $1.06 Million	-15,523 Reduced 15.18%	86,731 $0
Q3 2021 Jun 21, 2023	SELL	$51.4 - $68.2 $3.71 Million - $4.92 Million	-72,143 Reduced 45.41%	86,731 $0
Q3 2021 Mar 22, 2023	SELL	$51.4 - $68.2 $797,882 - $1.06 Million	-15,523 Reduced 15.18%	86,731 $0
Q3 2021 Nov 15, 2021	SELL	$51.4 - $68.2 $797,882 - $1.06 Million	-15,523 Reduced 15.18%	86,731 $477,000
Q2 2021 May 17, 2024	BUY	$44.1 - $84.0 $4.51 Million - $8.59 Million	102,254 New	102,254 $0
Q2 2021 Jun 21, 2023	SELL	$44.1 - $84.0 $2.5 Million - $4.76 Million	-56,620 Reduced 35.64%	102,254 $0
Q2 2021 Mar 22, 2023	SELL	$44.1 - $84.0 $898,890 - $1.71 Million	-20,383 Reduced 16.62%	102,254 $0
Q2 2021 Aug 16, 2021	BUY	$44.1 - $84.0 $4.51 Million - $8.59 Million	102,254 New	102,254 $750,000

Others Institutions Holding BNGO

# of Institutions

Shares Held

4.97K

Call Options Held

Put Options Held

View Full List

About Bionano Genomics, Inc.

Ticker BNGO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 290,140,000
Market Cap $133M
Description
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...

More about BNGO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account